Objective: To determine the long-term safety of flunisolide hydrofluoroalkane (HFA) in adults and adolescents with mild-to-moderate asthma. Design and Setting: A 1-year multicentre, randomised ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback